Paychex, Inc. Form 10-Q Summary
Reporting period: Third quarter and nine months ended February 28, 2022. The filing is for fiscal 2022 Q3, although the request metadata identifies 2021 Q3. Paychex is a human capital management software and services provider serving primarily small and medium-sized businesses in the United States and parts of Europe. It reports one operating segment.
Financial Results and Position
| Metric | Three months ended February 28, 2022 | Change | Nine months ended February 28, 2022 | Change |
|---|---|---|---|---|
| Total revenue | $1,276.0 million | 15% | $3,467.4 million | 15% |
| Service revenue | $1,261.6 million | 15% | $3,424.4 million | 15% |
| Operating income | $562.8 million | 20% | $1,446.0 million | 31% |
| Net income | $430.7 million | 23% | $1,096.4 million | 31% |
| Diluted EPS | $1.19 | 23% | $3.02 | 31% |
| Operating margin | 44.1% | Up from 42.2% | 41.7% | Up from 36.6% |
| Net cash from operations | Not separately provided | $1,168.3 million | Up from $870.6 million |
- Revenue mix: Management Solutions revenue was $959.9 million for the quarter and $2,597.4 million year to date, increasing 13% and 15%, respectively. PEO and Insurance Solutions revenue was $301.7 million for the quarter and $827.0 million year to date, increasing 21% and 16%, respectively.
- Interest revenue: Interest on funds held for clients declined 5% for the quarter to $14.4 million and 4% year to date to $43.0 million, reflecting lower average investment yields.
- Expenses: Total expenses increased 11% for the quarter to $713.2 million and 5% year to date to $2,021.4 million. The prior-year nine-month period included $32.2 million of one-time cost-saving initiative expenses.
- Adjusted results: Adjusted net income increased 20% for the quarter to $419.4 million and 27% year to date to $1,072.4 million. Adjusted diluted EPS was $1.15 and $2.95, respectively. These are non-GAAP measures.
- Cash flow and capital allocation: Year-to-date investing cash outflow was $1,168.1 million, including $7,450.1 million of purchases of available-for-sale securities, partially offset by $6,416.5 million of sales and maturities. Dividends paid were $714.9 million, compared with $670.5 million in the prior-year period.
- Liquidity: Cash, restricted cash, and total corporate investments were approximately $1.4 billion. Total short-term and long-term borrowings, net of debt issuance costs, were $806.3 million. Credit facilities provided approximately $1,991.3 million of unused availability at February 28, 2022.
- Balance sheet: Funds held for clients were $4,304.1 million and client fund obligations were $4,335.1 million. Total assets were $10,283.7 million and stockholders' equity was $3,286.0 million.
Material Changes Versus Prior Comparable Period
- Revenue growth was driven by stronger client additions and retention, increased checks per payroll, higher worksite employees and wages, improved revenue per client, ancillary HCM services, temporary-staffing payroll funding, and growth in PEO health insurance.
- Operating leverage improved materially: nine-month operating margin increased to 41.7% from 36.6%, helped by double-digit revenue growth and the absence of prior-year cost-saving initiative charges.
- Cash from operations increased $297.7 million year over year, while investing cash outflows increased $567.8 million primarily because of greater purchases of variable-rate demand notes, technology investment, and an acquisition.
- Net unrealized losses on available-for-sale securities increased to $30.9 million at February 28, 2022 from a $79.3 million net unrealized gain at May 31, 2021. Management attributed the change primarily to interest-rate movements and recorded no credit-loss impairment.
- Corporate investments increased substantially to $1,086.0 million from $36.7 million at May 31, 2021, while cash and cash equivalents declined to $267.5 million from $995.2 million.
- The quarterly dividend increased to $0.66 per share from $0.62 per share. No shares were repurchased during the quarter or during the nine months.
Outlook, Risks, and Unusual Items
- Management stated that the strong results continued through calendar year-end processing and the primary selling season, supported by strong sales, high client retention, and continued investment in technology and personnel.
- Paychex expects cash, corporate investments, operating cash flow, and available financing to support operations, capital expenditures, share repurchases, and dividends for the foreseeable future. No specific revenue or earnings guidance range is provided in the filing text.
- The COVID-19 pandemic continues to create uncertainty through economic disruption, labor and supply-cost inflation, hiring challenges, and changing client demand. The company had assisted clients in securing more than $7.0 billion of employee retention tax and paid-leave credits as of February 28, 2022.
- Interest-rate risk is significant. A hypothetical 25-basis-point increase in longer-term rates was estimated to reduce the fair value of the available-for-sale portfolio by approximately $20 million to $25 million. A 25-basis-point change in short-term rates was estimated to affect annual after-tax earnings by approximately $4.0 million to $4.5 million.
- The investment portfolio had approximately $105.9 million of net unrealized losses as of March 29, 2022, compared with $30.9 million at February 28, 2022. This subsequent-date information reflects market-rate volatility and is not a reported-period operating loss.
- Key risks include cybersecurity and data privacy, system outages, third-party service-provider failures, PEO co-employment and insurance claims, client credit losses, regulatory changes, acquisitions, litigation, labor availability, and continued COVID-19 effects.
- Workers' compensation and health insurance reserves depend on actuarial estimates and could change materially based on claims experience, legal developments, economic trends, and damage awards. Management did not identify any legal matter expected to have a material adverse effect, but noted inherent litigation uncertainty.
- The company amended credit facilities during the period, increasing one JPMorgan facility from $500 million to $750 million, extending its maturity to September 2026, and adopting provisions to phase out LIBOR.
Investor Verification Items
- Verify the filing period: the source is a Form 10-Q for the quarter ended February 28, 2022, not fiscal 2021 Q3.
- Reconcile GAAP results with non-GAAP adjusted net income, adjusted EPS, operating income, and EBITDA, particularly the impact of prior-year cost-saving charges and current-year tax benefits.
- Monitor interest-rate sensitivity, unrealized losses in the available-for-sale portfolio, and the effect of rising rates on both investment income and accumulated other comprehensive income.
- Review the relationship between funds held for clients and client fund obligations, including timing-related fluctuations in restricted cash and short-term borrowings.
- Assess PEO insurance reserves, workers' compensation claims, health-plan exposure, and the related letters of credit and self-insured obligations.
- Track client growth, retention, worksite employees, revenue per client, and temporary-staffing payroll funding, which were primary drivers of revenue growth.
- Confirm future dividend and share-repurchase decisions, as the filing states that dividends remain subject to Board discretion and no repurchases occurred during the period.